Imagia Canexia Health’s Follow It panel detects mutations in plasma. Plasma profiling (a type of liquid biopsy) can be used to help tailor treatment, monitor cancer progression, or detect treatment resistance.
If you are looking to manage your precision oncology program in your own laboratory, Imagia Canexia Health’s proprietary software platform puts the control back in your hands without the need for costly infrastructure overhead.
The Imagia Canexia Health Insights Platform seamlessly integrates with your internal systems to provide an accurate and high-throughput suite for molecular and computational genome analysis, quality assurance, interpretation, and report generation from targeted next-generation sequencing (NGS) data at the individual level.
The fully automated scalable system provides the security, traceability, data management, and performance required for NGS data analysis in a clinical setting.